Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
8 11 Search
2025
Selective Inhibition of Yersinia enterocolitica Type III Secretion by Lindera obtusiloba Extract and Cinnamtannin B1
Pharmaceutics
2025
Neurotransmitter 5-HT Further Promotes LL-37-Induced Rosacea-like Inflammation Through HTR3A
International Journal of Molecular Sciences
2025
Cannabidiol as a therapeutic agent for rosacea through simultaneous inhibition of multiple inflammatory pathways
BMB Reports
2024
Isosilybin A exhibits anti-inflammatory properties in rosacea by inhibiting MAPK pathway and M1 macrophage polarization
International Immunopharmacology
2024
Safety and Tolerability of Topical Trametinib in Rosacea: Results from a Phase I Clinical Trial
Skin Health and Disease
2024
In silico investigation of potential interleukin-8 (IL-8) and Cathelicidin (LL-37) inhibitors for rosacea treatment
Pharmacia
2024
Signaling pathways and targeted therapy for rosacea
Frontiers in Immunology
2022
AMPK Activation Enhances Neutrophil's Fungicidal Activity in Vitro and Improves the Clinical Outcome of Fusarium solani Keratitis in Vivo
Current Eye Research
Additional cited-by details will be shown when available from Crossref